glp 1 for slightly overweight GLP-1 Agonists In Obesity GLP-1 prescriptions increase by 364%

The FDAs approval was based on results from the Phase III CheckMate901 trial, where the combo regimen demonstrated a statistically significant improvement in overall survival and progression-free survival compared to cisplatin-gemcitabine alone, BMS reported

Trends Endocrinol Metab 31(6):410421

IBD is associated with the dysregulation of the symbiotic relationship between the commensal ecosystem and the mucosal immune system ( Crohns disease (CD) and ulcerative colitis (UC) are the two major phenotypes of IBD, and they differ meaningfully in their biology, barrier injury patterns, and epithelial restitution mechanisms

Weight Loss

Resistance training and physical activity are paramount for maintaining muscle mass during weight loss